Daniel D. Long sold $115K of SEPN stock

Daniel D. Long, SVP, Drug Discovery of Septerna, Inc. (SEPN), sold 3,334 shares of SEPN stock worth $115K, per an SEC Form 4 filed Aug 5, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 3, 2026, 2 days before it was made public.

SEPN has moved +19.7% since the trade date, from $34.98 to $41.86 (Nov 12, 2026 close).